ARCHIVES

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

This article is from The Cancer Letter archive.

Vol. 07 No. 48 | November 27, 1981

Download PDF Visit The Full Archive

Related Articles

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

September 17, 1976

NCI Cooperative Group Clinical Trials Approved

August 27, 2010